Search Results for 'Doi-Ticagrelor'

Doi-Ticagrelor published presentations and documents on DocSlides.

One-month Ticagrelor Monotherapy After     PCI in Acute Coronary Syndromes:
One-month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes:
by yvonne
Principal Results From the Double-blind, Placebo-c...
Prasugrel  vs  ticagrelor in acute coronary syndromes
Prasugrel vs ticagrelor in acute coronary syndromes
by tawny-fly
Giuseppe . Biondi-Zoccai. , MD. Sapienza Universi...
Ticagrelor compared with clopidogrel in patients with acute
Ticagrelor compared with clopidogrel in patients with acute
by tatyana-admore
PLAT. elet Inhibition and patient . O. utcomes tr...
wvwvyzwvxv
wvwvyzwvxv
by eddey
coronary intervention PCI1920 As new antithromboti...
Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD,
Francesco Franchi, MD, Fabiana Rollini, MD, Jose Rivas Rios, MD, Andrea Rivas, MD,
by shiloh201
Malhar Agarwal, MD, Megha Kureti, MD, Deepa Nagara...
Aspirin (n = 6,610) Ticagrelor
Aspirin (n = 6,610) Ticagrelor
by danya
(n . = 6,589). SOCRATES. Primary outcome, death, M...
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
by eloise
ORIGIN. Pierre . Amarenco. , Hans . Denison. , . S...
T icagrelor  W ith Asp I
T icagrelor W ith Asp I
by terrificycre
rin or A. L. one . I. n Hi. GH. -Risk Patients Aft...
Antiplatelet Agents Mohammad Sistanizad
Antiplatelet Agents Mohammad Sistanizad
by blindnessinfluenced
Associate Professor of Clinical Pharmacy,. SBMU. C...
Reduction in Ischemic Events with
Reduction in Ischemic Events with
by natalia-silvester
Ticagrelor. in Diabetic Patients from the PEGASU...
Long-Term Tolerability of
Long-Term Tolerability of
by briana-ranney
Ticagrelor. for Secondary Prevention: . Insights...
Predictive
Predictive
by lindy-dunigan
safety study . of . ticagrelor's. degradation co...
Predictive
Predictive
by kittie-lecroy
safety study . of . ticagrelor's. degradation co...
Practice Plus Webinar June 23
Practice Plus Webinar June 23
by bitsy
rd. . 2021 . Steve Williams. Lead Clinical Pharma...
Cangrelor : Friend or Foe? -
Cangrelor : Friend or Foe? -
by ariel
Cangrelor. : Not the CHAMPION We Hoped For. James ...
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
by GratefulHeart
Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by marina-yarberry
ACCP Cardiology PRN Journal Club 27 September 20...
Antiplatelet  Therapy for Secondary Prevention in the First Year Following
Antiplatelet Therapy for Secondary Prevention in the First Year Following
by calandra-battersby
Antiplatelet Therapy for Secondary Prevention in...
Bonferroni: Friend or Foe?
Bonferroni: Friend or Foe?
by alexa-scheidler
Multiple Testing in Cardiovascular Medicine. Dhru...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
STEMI Update 2017 Cardiology Today
STEMI Update 2017 Cardiology Today
by alida-meadow
Michael C Fraizer, MD. Iowa Heart Center. Feb 4, ...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by tatiana-dople
Announcements . Thank you attending the ACCP Card...
Canadian Diabetes Association Clinical Practice Guidelines
Canadian Diabetes Association Clinical Practice Guidelines
by test
Acute Coronary Syndromes and Diabetes. Chapter 26...
DOI httpsdoiorg10472750032745X320Volume 107 Issue 2
DOI httpsdoiorg10472750032745X320Volume 107 Issue 2
by melanie
Pages: 1-3 This study was conducted to characteriz...
Bull World Health Organ doi httpdxdoiorg102471BLT17206466Research
Bull World Health Organ doi httpdxdoiorg102471BLT17206466Research
by joy
Male partners and maternity care in Burkina FasoMa...
JournalofStatisticalSoftwareSeptember2016,Volume73,Issue4.doi:10.18637
JournalofStatisticalSoftwareSeptember2016,Volume73,Issue4.doi:10.18637
by ruby
JSS LookingBackattheGiSystemofNonlinearMultiv...
https://doi.org/10.5194/amt-2019-326
https://doi.org/10.5194/amt-2019-326
by della
Preprint.Discussionstarted:10September2019c Author...
DOI MSP Risk Mitigation/Waiver Process Training
DOI MSP Risk Mitigation/Waiver Process Training
by olivia-moreira
RM/W Process Overview. Definition of the Process ...
Bowl and Doily Spider
Bowl and Doily Spider
by lindy-dunigan
By: . Averie. The male and female are about 1/5 ...
Bowl and doily spiders
Bowl and doily spiders
by marina-yarberry
By. : Raina . H.. B. owl and doily spiders make a...
Bowl and Doily Spider
Bowl and Doily Spider
by lois-ondreau
By: Taylor H.. The Bowl and Doily spider is abou...
some fly techniques windless indoor. I assume that those who want to f
some fly techniques windless indoor. I assume that those who want to f
by sherrill-nordquist
http://www.kitelife.com/archive http://www.kitelif...
DOI assignment within the ARGO international project
DOI assignment within the ARGO international project
by tatiana-dople
Fred . Merceur. , Ifremer. DataCite. Annual Conf...
Nickels,http://dx.doi.org/10.1016/j.repl.2015.02.015
Nickels,http://dx.doi.org/10.1016/j.repl.2015.02.015
by ellena-manuel
ReinforcedVolumewww.reinforcedplastics.com TheAero...
DOING BUSINESS 2019 Training for Reform TRADING
DOING BUSINESS 2019 Training for Reform TRADING
by liane-varnes
DOING BUSINESS 2019 Training for Reform TRADING AC...
Workflow Group
Workflow Group
by hendrix685
Publications and Reports. Group Leads: . Dean N. W...
Reducing anticoagulant-related harm
Reducing anticoagulant-related harm
by jerry
A review of quality improvement initiatives. 16 Ju...